National Vision Beats Q2 Profit Estimates, Raises Full-Year Outlook
EYE sits 53% above its 52-week low of $14.75.
Summary
National Vision delivered a mixed Q2: revenue of $498.8M slightly missed the $500.3M consensus, but adjusted EPS of $0.25 crushed the $0.19 estimate, and adjusted operating income of $31.6M far exceeded the $23.7M forecast. The beat was driven by higher-value transactions, managed care growth, and cost discipline. More importantly, the company raised its full-year adjusted operating income guidance to $119M-$139M (from $107M-$133M) and EPS to $0.94-$1.09 (from $0.85-$1.09), while narrowing comp sales growth to 3%-5%. This follows a strong Q1 and reaffirmed guidance in June, signaling sustained momentum. The stock, trading at 20x forward earnings, could re-rate as the raised outlook implies accelerating profitability.
At the time of this announcement, EYE was trading at $22.56 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $1.8B. The 52-week trading range was $14.75 to $30.02. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.